journal article·2023-01-17Open access

Gallium-Doped Hydroxyapatite Shows Antibacterial Activity against Pseudomonas aeruginosa without Affecting Cell Metabolic Activity

Marika Mosina, Claudia Siverino, Liga Stipniece, Artemijs Sceglovs, Renats Vasiljevs, T. Fintan Moriarty, Janis Locs

Abstract

Calcium phosphates (CaPs) have been used in bone regeneration for decades. Among the described CaPs, synthetic hydroxyapatite (HAp) has a chemical composition similar to that of natural bone. Gallium-containing compounds have been studied since the 1970s for the treatment of autoimmune diseases and have shown beneficial properties, such as antibacterial activity and inhibition of osteoclast activity. In this study, we synthesized hydroxyapatite (HAp) powder with Ga doping ratios up to 6.9 ± 0.5 wt% using the wet chemical precipitation method. The obtained products were characterized using XRD, BET, FTIR, and ICP-MS. Ga3+ ion release was determined in the cell culture media for up to 30 days. Antibacterial activity was assessed against five bacterial species: Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Streptococcus pyogenes. The biocompatibility of the GaHAp samples was determined in human fibroblasts (hTERT-BJ1) through direct and indirect tests. The structure of the synthesized products was characteristic of HAp, as revealed with XRD and FTIR, although the addition of Ga caused a decrease in the crystallite size. Ga3+ was released from GaHAp paste in a steady manner, with approximately 40% being released within 21 days. GaHAp with the highest gallium contents, 5.5 ± 0.1 wt% and 6.9 ± 0.5 wt%, inhibited the growth of all five bacterial species, with the greatest activity being against Pseudomonas aeruginosa. Biocompatibility assays showed maintained cell viability (~80%) after seven days of indirect exposure to GaHAp. However, when GaHAp with Ga content above 3.3 ± 0.4 wt% was directly applied on the cells, a decrease in metabolic activity was observed on the seventh day. Overall, these results show that GaHAp with Ga content below 3.3 ± 0.4 wt% has attractive antimicrobial properties, without affecting the cell metabolic activity, creating a material that could be used for bone regeneration and prevention of infection.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Rudolfs Cimdins Riga Biomaterials Innovation and Development Centre, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka 3, LV-1007 Riga, Latvia

Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, LV-1048 Riga, Latvia

AO Research Institute Davos, 7270 Davos, Switzerland

Funding

EuroNanoMedIII · European Union’s Horizon 2020 research and innovation program

References (57)

Show source-provided references
1. Ben-Nissan, B. (2014). Advances in Calcium Phosphate Biomaterials, Springer.10.1007/978-3-642-53980-0 ↗
2. Bioactive Calcium Phosphate Materials and Applications in Bone Regeneration10.1186/s40824-018-0149-3 ↗
3. Samavedi, S., Poindexter, L.K., Van Dyke, M., and Goldstein, A.S. (2014). Synthetic Biomaterials for Regenerative Medicine Applications, Elsevier Inc.10.1016/B978-0-12-398523-1.00007-0 ↗
4. Calcium Phosphate Cement: Review of Mechanical and Biological Properties10.1111/j.1532-849X.2006.00129.x ↗
5. Calcium Phosphate Scaffolds Combined with Bone Morphogenetic Proteins or Mesenchymal Stem Cells in Bone Tissue Engineering10.4103/0366-6999.155121 ↗
6. Calcium Phosphate Resorbable Ceramics: A Potential Alternative to Bone Grafting
7. Immediate Dental Root Implants from Synthetic Dense Calcium Hydroxylapatite10.1016/0022-3913(79)90253-1 ↗
8. Particle Size of Periodontal Bone Grafting Materials10.1902/jop.1984.55.7.406 ↗
9. Interaction of Biodegradable β-Whitlockite Ceramics with Bone Tissue: An in Vivo Study10.1016/0142-9612(85)90008-0 ↗
10. Brown, W.E., and Chow, L.C.C. (1986). A New Calcium Phosphate, Water–Setting Cement. Acc. Chem. Res., 351–379.
11. Calcium Phosphates and Bone Induction
12. Study of Hydroxyapatite Osteoinductivity with an Osteogenic Differentiation of Mesenchymal Stem Cells10.1002/jbm.a.31994 ↗
13. Potential Osteoinductive Effects of Hydroxyapatite Nanoparticles on Mesenchymal Stem Cells by Endothelial Cell Interaction10.1186/s11671-021-03522-1 ↗
14. Infection of Orthopedic Implants with Emphasis on Bacterial Adhesion Process and Techniques Used in Studying Bacterial-Material Interactions10.4161/biom.22905 ↗
15. The Significance of Infection Related to Orthopedic Devices and Issues of Antibiotic Resistance10.1016/j.biomaterials.2005.11.044 ↗
16. Gallium Containing Calcium Phosphates: Potential Antibacterial Agents or Fictitious Truth10.1016/j.actbio.2022.07.063 ↗
17. Early Complications from the Use of Calcium Phosphate Paste in Mandibular Lengthening Surgery. A Retrospective Study10.1016/j.joms.2017.01.017 ↗
18. Mokabber, T. (2020). Electrochemically Deposited Antimicrobial Hydroxyapatite Coatings, University of Groningen.
19. Substituted Hydroxyapatite: A Recent Development10.1080/10667857.2019.1664096 ↗
20. Ion Adsorption Behaviour of Hydroxyapatite with Different Crystallinities10.1016/j.colsurfb.2009.06.031 ↗
21. The Antimicrobial Activity of Nanoparticles: Present Situation and Prospects for the Future10.2147/IJN.S121956 ↗
22. Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal10.1002/anie.201205923 ↗
23. Copper Substituted Hydroxyapatite and Fluorapatite: Synthesis, Characterization and Antimicrobial Properties10.1016/j.ceramint.2014.07.086 ↗
24. Biological Properties of Copper-Doped Biomaterials for Orthopedic Applications: A Review of Antibacterial, Angiogenic and Osteogenic Aspects10.1016/j.actbio.2020.09.044 ↗
25. Metallic Ions as Therapeutic Agents in Tissue Engineering Scaffolds: An Overview of Their Biological Applications and Strategies for New Developments10.1098/rsif.2011.0611 ↗
26. Gallium as an Antibacterial Agent: A DFT/SMD Study of the Ga3+/Fe3+ Competition for Binding Bacterial Siderophores10.1021/acs.inorgchem.0c00367 ↗
27. Gallium-Based Anti-Infectives: Targeting Microbial Iron-Uptake Mechanisms10.1016/j.coph.2013.07.001 ↗
28. Influences of Gallium Substitution on the Phase Stability, Mechanical Strength and Cellular Response of β-Tricalcium Phosphate Bioceramics10.1016/j.ceramint.2020.03.195 ↗
29. Designing Ga(III)-Containing Hydroxyapatite with Antibacterial Activity10.1039/C6RA23424K ↗
30. A Preliminary Investigation into the Structure, Solubility and Biocompatibility of Solgel SiO2-CaO-Ga2O3 Glass-Ceramics10.1016/j.matchemphys.2014.08.006 ↗
31. Antimicrobial Activity of Metals: Mechanisms, Molecular Targets and Applications10.1038/nrmicro3028 ↗
32. The Transition Metal Gallium Disrupts Pseudomonas Aeruginosa Iron Metabolism and Has Antimicrobial and Antibiofilm Activity10.1172/JCI30783 ↗
33. Antibacterial Nanocomposite of Functionalized Nanogold and Gallium-Doped Hydroxyapatite10.1016/j.matlet.2017.01.092 ↗
34. The Antibacterial Activity of Ga3+ Is Influenced by Ligand Complexation as Well as the Bacterial Carbon Source10.1128/AAC.00386-11 ↗
35. Densification of Amorphous Calcium Phosphate Using Principles of the Cold Sintering Process10.1016/j.jeurceramsoc.2020.08.074 ↗
36. Luminescence Properties of Zirconia Nanocrystals Prepared by Solar Physical Vapor Deposition10.1016/j.optmat.2014.06.003 ↗
37. Human Fibroblast Reactions to Standard and Electropolished Titanium and Ti-6Al-7Nb, and Electropolished Stainless Steel10.1002/jbm.a.30457 ↗
38. Phase Composition and Crystallinity of Hydroxyapatite with Various Heat Treatment Temperatures10.22159/ijap.2017.v9s2.21 ↗
39. Different Behavior of Implanted Hydroxyapatite Depending on Morphology, Size and Crystallinity10.2109/jcersj.114.760 ↗
40. FTIR and XRD Evaluation of Carbonated Hydroxyapatite Powders Synthesized by Wet Methods
41. Spectroscopic Characterisation of Hydroxyapatite and Nanocrystalline Apatite with Grafted Aminopropyltriethoxysilane: Nature of Silane–Surface Interaction10.1007/s10853-015-9122-x ↗
42. Pajor, K., Pajchel, Ł., Zgadzaj, A., Piotrowska, U., and Kolmas, J. (2020). Modifications of Hydroxyapatite by Gallium and Silver Ions—Physicochemical Characterization, Cytotoxicity and Antibacterial Evaluation. Int. J. Mol. Sci., 21.10.3390/ijms21145006 ↗
43. Evaluation of In Vitro Toxicity of Hydroxyapatite Doped with Gallium10.1016/j.matlet.2019.06.095 ↗
44. Hydrothermal Synthesis of Hydroxyapatite Assisted by Gemini Cationic Surfactant10.1155/2020/6173867 ↗
45. On the Crystallization of Hydroxyapatite under Hydrothermal Conditions: Role of Sebacic Acid as an Additive10.1021/acsomega.0c03297 ↗
46. Effect of Gallium on the in Vitro Formation, Growth, and Solubility of Hydroxyapatite10.1007/BF02561406 ↗
47. Tite, T., Popa, A.C., Balescu, L.M., Bogdan, I.M., Pasuk, I., Ferreira, J.M.F., and Stan, G.E. (2018). Cationic Substitutions in Hydroxyapatite: Current Status of the Derived Biofunctional Effects and Their in Vitro Interrogation Methods. Materials, 11.10.3390/ma11112081 ↗
48. Vrchovecká, K., Pávková-Goldbergová, M., Engqvist, H., and Pujari-Palmer, M. (2022). Cytocompatibility and Bioactive Ion Release Profiles of Phosphoserine Bone Adhesive: Bridge from In Vitro to In Vivo. Biomedicines, 10.10.3390/biomedicines10040736 ↗
49. Ion Release from Hydroxyapatite and Substituted Hydroxyapatites in Different Immersion Liquids: In Vitro Experiments and Theoretical Modelling Study10.1098/rsos.201785 ↗
50. Calcium Deficiency in Hydroxyapatite and Its Drug Delivery Applications10.1049/mnl.2016.0675 ↗
51. Promises and Failures of Gallium as an Antibacterial Agent10.2217/fmb.14.3 ↗
52. The Bacterial Cell Envelope10.1101/cshperspect.a000414 ↗
53. Gasser, V., Kuhn, L., Hubert, T., Aussel, L., Hammann, P., and Schalk, I.J. (2021). The Esterase PfeE, the Achilles’ Heel in the Battle for Iron between Pseudomonas Aeruginosa and Escherichia Coli. Int. J. Mol. Sci., 22.10.3390/ijms22062814 ↗
54. New Hydroxyapatite Nanophases with Enhanced Osteogenic and Anti-Bacterial Activity10.1002/jbm.a.36249 ↗
55. Competition between Abiogenic and Biogenic Metal Cations in Biological Systems: Mechanisms of Gallium‘s Anticancer and Antibacterial Effect10.1016/j.jinorgbio.2020.111309 ↗
56. Gallium Complexes as New Promising Metallodrug Candidates10.1016/j.ica.2012.06.003 ↗
57. The Response of Pre-Osteoblasts and Osteoclasts to Gallium Containing Mesoporous Bioactive Glasses10.1016/j.actbio.2018.06.036 ↗